Skip to main content
Log in

Cardiogenic shock in a 28-year-old woman associated with sibutramine use

  • Case Report
  • Published:
International Journal of Legal Medicine Aims and scope Submit manuscript

Abstract

A 28-year-old woman collapsed in her home, and her companion rushed to call emergency services. Upon arrival, a physician performed CPR and endotracheal intubation, successfully restoring her voluntary heart rhythm. However, while en route to the hospital, ventricular fibrillation recurred. Despite the restoration of her voluntary rhythm through electrical defibrillation, she remained in a comatose state, which eventually led to multiple organ failures. Family members revealed that she had a 2-month history of taking diet pills. Histological examination revealed cardiomyocyte necrosis, contraction band necrosis, interstitial hemorrhage, collagen deposition, interstitial fiber proliferation, and myofiber remodeling. Analysis of blood and urine using GC–MS and LC–MS detected sibutramine and its primary metabolites, M1 and M2, which were consistent with the composition of the medication she was taking. The deceased was in good health with no underlying heart disease. The above information confirmed that the cause of her death was sibutramine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data availability

The authors confirm that the data supporting the findings of this study are available within the article.

References

  1. Risk Factor Collaboration NCD, (NCD-RisC) (2017) Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet (London, England) 390:2627–2642. https://doi.org/10.1016/S0140-6736(17)32129-3

    Article  Google Scholar 

  2. Health Effects of Overweight and Obesity in 195 Countries over 25 Years (2017) N Engl J Med 377(1):13–27. https://doi.org/10.1056/NEJMoa1614362

  3. Connoley IP, Liu YL, Frost I, Reckless IP, Heal DJ, Stock MJ (1999) Thermogenic effects of sibutramine and its metabolites. Br J Pharmacol 126:1487–1495. https://doi.org/10.1038/sj.bjp.0702446

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Scheen AJ (2010) Cardiovascular risk-benefit profile of sibutramine: American Journal Cardiovascular. Drugs 10:321–334. https://doi.org/10.2165/11584800-000000000-00000

    Article  CAS  Google Scholar 

  5. James WPT, Caterson ID, Coutinho W, Finer N, Van Gaal LF, Maggioni AP et al (2010) Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med 363:905–917. https://doi.org/10.1056/NEJMoa1003114

    Article  CAS  PubMed  Google Scholar 

  6. Samsky MD, Morrow DA, Proudfoot AG, Hochman JS, Thiele H, Rao SV (2021) Cardiogenic shock after acute myocardial infarction: a review. JAMA 326:1840–1850. https://doi.org/10.1001/jama.2021.18323

    Article  PubMed  PubMed Central  Google Scholar 

  7. Morikawa Y, Shibata A, Okumura N, Ikari A, Sasajima Y, Suenami K et al (2017) Sibutramine provokes apoptosis of aortic endothelial cells through altered production of reactive oxygen and nitrogen species. Toxicol Appl Pharmacol 314:1–11. https://doi.org/10.1016/j.taap.2016.11.003

    Article  CAS  PubMed  Google Scholar 

  8. Morikawa Y, Shibata A, Sasajima Y, Suenami K, Sato K, Takekoshi Y et al (2018) Sibutramine facilitates apoptosis and contraction of aortic smooth muscle cells through elevating production of reactive oxygen species. Eur J Pharmacol 841:113–121. https://doi.org/10.1016/j.ejphar.2018.10.009

    Article  CAS  PubMed  Google Scholar 

  9. Oberholzer HM, Van Der Schoor C, Taute H, Bester MJ (2015) A descriptive study to provide evidence of the teratogenic and cellular effects of sibutramine and ephedrine on cardiac- and liver-tissue of chick embryos. Microsc Res Tech 78:737–746. https://doi.org/10.1002/jemt.22539

    Article  CAS  PubMed  Google Scholar 

  10. Eroglu E, Gemici G, Bayrak F, Kalkan AK, Degertekin M (2009) Acute myocardial infarction in a 24 year-old man possibly associated with sibutramine use. Int J Cardiol 137:e43–e45. https://doi.org/10.1016/j.ijcard.2008.06.017

    Article  PubMed  Google Scholar 

  11. Ernest D, Gershenzon A, Corallo CE, Nagappan R (2008) Sibutramine-associated QT interval prolongation and cardiac arrest. Ann Pharmacother 42:1514–1517. https://doi.org/10.1345/aph.1L129

    Article  CAS  PubMed  Google Scholar 

  12. Shah MS, Patel ZK, Bharucha R, Talati T, Benz M (2022) Sibutramine-induced nonischemic cardiomyopathy. Cureus 14:e21650. https://doi.org/10.7759/cureus.21650

    Article  PubMed  PubMed Central  Google Scholar 

  13. Heo SH, Kang M-H (2013) A case of dilated cardiomyopathy with massive left ventricular thrombus after use of a sibutramine-containing slimming product. Korean Circ J 43:632–635. https://doi.org/10.4070/kcj.2013.43.9.632

    Article  PubMed  PubMed Central  Google Scholar 

  14. Harrison-Woolrych M, Clark DWJ, Hill GR, Rees MI, Skinner JR (2006) QT interval prolongation associated with sibutramine treatment. Br J Clin Pharmacol 61:464–469. https://doi.org/10.1111/j.1365-2125.2006.02574.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Yim K-MA, Ng HW, Chan C-K, Yip G, Lau FL (2008) Sibutramine-induced acute myocardial infarction in a young lady. Clin Toxicol (Phila) 46:877–879. https://doi.org/10.1080/15563650802136258

    Article  CAS  PubMed  Google Scholar 

  16. Pöss J, Böhm M, Link A (2010) 32-jährige Patientin mit akutem Myokardinfarkt der Hinterwand unter Einnahme des Appetitzüglers Sibutramin. DMW - Deut Med Wochenschr 135:965–968. https://doi.org/10.1055/s-0030-1253684

    Article  Google Scholar 

  17. Azarisman SM, Magdi YA, Noorfaizan S, Oteh M (2007) Myocardial infarction induced by appetite suppressants in Malaysia. N Engl J Med 357:1873–1874. https://doi.org/10.1056/NEJMc070990

    Article  CAS  PubMed  Google Scholar 

  18. Gómez-Barrado JJ, Turégano S, Garcipérez de Vargas FJ, Porras Y (2010) Acute coronary syndrome in a young woman treated with sibutramine. Rev Esp Cardiol 63:243

    Article  PubMed  Google Scholar 

  19. Rodriguez-Guerra M, Yadav M, Bhandari M, Sinha A, Bella JN, Sklyar E (2021) Sibutramine as a cause of sudden cardiac death. Case Rep Cardiol 2021:8896932. https://doi.org/10.1155/2021/8896932

    Article  PubMed  PubMed Central  Google Scholar 

  20. Kim K-S, Kim E-J, Lee H-A, Park S-J (2009) Effect of sibutramine HCl on cardiac hERG K+ channel. Mol Cell Biochem 320:125–131. https://doi.org/10.1007/s11010-008-9914-2

    Article  CAS  PubMed  Google Scholar 

  21. Rodriguez-Guerra M, Yadav M, Bhandari M, Sinha A, Bella JN, Sklyar E (2021) Case Rep Cardiol 2021:8896932. https://doi.org/10.1155/2021/8896932

    Article  PubMed  PubMed Central  Google Scholar 

  22. Skalicka-Woźniak K, Georgiev MI, Orhan IE (2017) Adulteration of herbal sexual enhancers and slimmers: the wish for better sexual well-being and perfect body can be risky. Food Chem Toxicol 108:355–364. https://doi.org/10.1016/j.fct.2016.06.018

    Article  CAS  PubMed  Google Scholar 

  23. Tucker J, Fischer T, Upjohn L, Mazzera D, Kumar M (2018) Unapproved pharmaceutical ingredients included in dietary supplements associated with US Food and Drug Administration warnings. JAMA Netw Open 1:e183337. https://doi.org/10.1001/jamanetworkopen.2018.3337

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Yunyun Wang or Liang Liu.

Ethics declarations

Informed consent

Written informed consent was obtained from the family members of the patient.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wan, R., Song, H., Qu, G. et al. Cardiogenic shock in a 28-year-old woman associated with sibutramine use. Int J Legal Med 138, 833–838 (2024). https://doi.org/10.1007/s00414-023-03147-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00414-023-03147-2

Keywords

Navigation